CMS Energy profits rise, 2022 guidance raised
JACKSON—CMS Energy, the electric and gas utility, reported net income of $1.33 billion or $4.66 a share for 2021, up from $752 million or $2.64 a share in 2020. Revenue …
Meritor quarterly net jumps
TROY–The transportation supplier Meritor Inc. (NYSE: MTOR) posted net income of $62 million or 87 cents a share in the quarter ended Sept. 30, up from $1 million or 1 …
CMS Energy earnings dip on jump in operating expenses
JACKSON—CMS Energy Corp. (NYSE: CMS), the Jackson-based utility holding company, reported net income of $183 million or 64 cents a share in the third quarter, down from $210 million or …
TriMas reports higher sales, earnings
BLOOMFIELD HILLS—Officials at the Bloomfield Hills diversified manufacturer TriMas Corp. (Nasdaq: TRS) Thursday reported net income of $19.6 million or 45 cents a share in the third quarter, compared to …
Ford profit slips
DEARBORN—Ford Motor Co. reported net income of $1.83 billion or 45 cents a share in the third quarter, down from $2.39 billion or 60 cents a share in the same …
Lear returns to profit as economy recovers
SOUTHFIELD—Lear Corp. (NYSE: LEA), the Southfield-based manufacturer of automotive seating and economics, reported net income of $175.2 million or $2.89 a share in the fiscal quarter ended July 3, compared …
Auto recovery boosts Superior Industries
SOUTHFIELD—Superior Industries International Inc. (NYSE: SUP), the aluminum automotive wheel manufacturer, reported net income of $1.7 million in the second quarter ended June 30, up from a loss of $43.2 …
Horizon Global moves back to profit
PLYMOUTH—Horizon Global Corp. (NYSE: HZN), the manufacturer of towing and trailering equipment, reported net income of $960,000 or 4 cents a share in the second quarter ended June 30, up …
Shyft Group sales, profits jump
NOVI—Shyft Group Inc., the specialty vehicle manufacturer, reported net income of $16 million or 44 cents a share in the second quarter ended June 30, up from a loss of …
Esperion boosts sales of cholesterol-busting drugs
ANN ARBOR—The pharmaceutical firm Esperion Therapeutics Inc. (Nasdaq: ESPR) reported a rise in sales of its novel cholesterol-reducing drugs in the second quarter ended June 30 but still posted a …